BioSpace News Archive

Ligand Pharmaceuticals Incorporated today announced that its partner Gloria Biosciences (GloriaBio) has received approval from China’s National Medical Products Administration (NMPA) for zimberelimab (GLS-010), an OmniAb-derived anti-PD-1 monoclonal antibody for the treatment of recurrent or refractory classical Hodgkin’s lymphoma (cHL).

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced that management will present a company update at the following virtual investor conferences

Adesis, Inc. today announced that Linda Choi MacDonald has joined the company as Chief Operating Officer.

NEUVOGEN, an immunoncology company, is pleased to announce the appointment of Dr. Jack Bui to its Scientific Advisory Board (“SAB”) effective August 30, 2021 .

Catalent, Inc., the leading global provider of development sciences and manufacturing platforms for medicines, including biotherapeutics; cell and gene therapies; and consumer health products, announced financial results for the fourth quarter of fiscal 2021, which ended June 30, 2021.

Aptose Biosciences Inc., a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, announced that the Aptose management team will participate at the upcoming conferences in September 2021

Bioventus Inc. has elected to make a $50 million escrow payment pursuant to its Option and Equity Purchase Agreement with CartiHeal Ltd., signaling its intent to move forward with an acquisition of CartiHeal.

Strongbridge Biopharma plc (Nasdaq: SBBP) (“Strongbridge”) today announced that the leading independent proxy advisory firm Institutional Shareholder Services (“ISS”) has recommended that Strongbridge shareholders vote “FOR” the Company’s transaction with Xeris Pharmaceuticals (Nasdaq: XERS) (“Xeris”).

Convergent Therapeutics today announced the appointment of Alexander Brown to the newly created position of Chief Operating Officer.

NorthStar Medical Radioisotopes , LLC, announced today that it has been awarded $37 million in cooperative agreement funds with the U.S. Department of Energy’s National Nuclear Security Administration